Aurora B expression as a prognostic indicator and possibile therapeutic target in oral squamous cell carcinoma

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 79-88

  Pannone, G ^a   Hindi, S A H ^b   Santoro, A ^a   Sanguedolce, Francesca ^a   Rubini, C ^c   Cincione, R I ^a   De Maria, S ^d   Tortorella, S ^e   Rocchetti, R ^c   Cagiano, S ^a   Pedicillo, C ^a   Serpico, R ^d   Lo Muzio, L ^a   Bufo, P ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BABYLON   (Iraq)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Aurora B; Immunohistochemistry; Oral cancer; Prognostic factor

Indexed keywords

AURORA B KINASE; AURKB PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; THREONINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; FOLLOW UP; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; WESTERN BLOTTING; CANCER PROGNOSIS; CARCINOGENESIS; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; MOUTH SQUAMOUS CELL CARCINOMA; ORAL CANCER CELL LINE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES;

EID: 79957914407     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400110     Document Type: Article

References (30)

1. Johnson N, Franceschi S, Ferlay J, Ramadas K, Schmid S, MacDonald DG, Bouquot JE, Slootweg PJ. Squamous cell carcinoma. In WHO Classification of Tumours - Pathology and Genetics of Tumours of the Head and Neck, Barnes L, Eveson J, Reichart P, Sidransky D (eds). IARCPress: Lyon 2005; p. 168-75.
2. Marumoto T, Zhang D, Saya H. Aurora-A - A guardian of poles. Nat Rev Cancer 2005; 5:42-50. (Pubitemid 40052324)
3. Goto H, Yasui Y, Nigg EA, Inagaki M. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 2002; 7:11-17. (Pubitemid 34121301)
4. Lee ECY, Frolov A, Li R, Ayala G, Greenberg NM. Targeting aurora kinases for the treatment of prostate cancer. Cancer Research 2006; 66:4996-5002. (Pubitemid 43844918)
5. Wheatley SP, Henzing AJ, Dodson H, Khaled W, Earnshaw WC. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J Biol Chem 2004; 279:5655-60. (Pubitemid 38220593)
6. Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M. Increased mitotic phosphorylation of Histone H3 attributable to AIM-1/ Aurora-B overexpression contributes to chromosome number instability. Cancer Res 2002; 62:5168-77. (Pubitemid 35024587)
7. Zeng WF, Navaratne K, Prayson RA, Weil RJ. Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme. J Clin Pathol 2007; 60:218-21.
8. Sorrentino R, Libertini S, Pallante PL, et al. Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 2005; 90:928-35. (Pubitemid 40279218)
9. Katayama H, Ota T, Jisaki F, Ueda Y, Tanaka T, Odashima S, Suzuki F, Terada Y, Tatsuka M. Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst 1999; 91:1160-62. (Pubitemid 29330556)
10. Araki K, Nozaki K, Ueba T, Tatsuka M, Hashimoto N. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J Neurooncol 2004; 67:53-64. (Pubitemid 38418249)
11. Chieffi P, Cozzolino L, Kisslinger A, et al. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 2006; 15:326-33. (Pubitemid 43191232)
12. Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BSMS, Shimamoto F, Tatsuka M, Takata T. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Archiv 2007; 450:297-302. (Pubitemid 46376560)
13. Yoshihiro Y, Takeshi U, Aie K, et al. Autophosphorylation of a Newly Identified Site of Aurora-B Is Indispensable for Cytokinesis. J Biolog Chem 2004; 279:12997-13003.
14. Steeghs N, Eskens FA, Gelderblom H, et al Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors. J Clin Oncol 2009; 27:5094-101.
15. Yeung SC, Gully C, Lee MH. Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 2008; 8:1514-25.
16. Slootweg PJ, Eveson JW. Tumours of the oral cavity and oropharynx: Introduction. In WHO Classification of Tumours - Pathology and Genetics of Tumours of the Head and Neck, Barnes L, Eveson J, Reichart P, Sidransky D (eds). IARCPress: Lyon; 2005; p. 164-5.
17. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983; 51:2175-80. (Pubitemid 13106840)
18. Pannone G, Sanguedolce F, De Maria S, et al. Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. Int J Immunopathol Pharmacol 2007; 20:317-324. (Pubitemid 47104851)
19. Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumourigenesis. Mol Cancer Res 2007; 5:1-10.
20. Chieffi P, Troncone G, Caleo A, Libertini S, Linardopoulos S, Tramontano D, Portella G. Aurora B expression in normal testis and seminomas. J Endocrinology 2004; 181:263-270. (Pubitemid 38744675)
21. Smith SL, Bowers NL, Betticher DC, Gautschi O, Ratschiller D, Hoban PR, Booton R, Santibáñez-Koref MF, Heighway J. Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer 2005; 93:719-29. (Pubitemid 41486464)
22. Kanda A, Kawai H, Suto S, Kitajima S, Sato S, Takata T, Tatsuka M. Aurora B/AIM-1 kinase activity is involved in Ras-mediated cell transformation. Oncogene 2005; 24:7266-72. (Pubitemid 41622230)
23. Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001; 11:49-54. (Pubitemid 32144751)
24. Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007; 8:798-812. (Pubitemid 47462135)
25. De Maria S, Pannone G, Bufo P, et al. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol 2009; 135:107-116.
26. Bolanos-Garcia VM. Aurora kinases. Int J Biochem Cell Biol 2005; 37:1572-77. (Pubitemid 40719637)
27. Bolton MA, Lan W, Powers SE, McCleland ML, Kuang J, Stukenberg PT. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol Biol Cell 2002; 13:3064-77. (Pubitemid 35034246)
28. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 2002; 115:575-85. (Pubitemid 34182984)
29. Pan C, Yan M, Yao J, Xu J, Long Z, Huang H, Liu Q. Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells. Oral Oncol 2008; 44:639-45. (Pubitemid 351842815)
30. Young MA, Shah NP, Chao LH, Seeliger M, Milanov ZV, Biggs WH 3rd, Treiber DK, Patel HK, Zarrinkar PP, Lockhart DJ, Sawyers CL, Kuriyan J. Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680. Cancer Res 2006; 66:1007-14. (Pubitemid 43168337)